In a bid to sweeten its deal for Fortis Healthcare, Manipal Health Enterprises has proposed merging of both enterprises that pegs the value of the beleaguered Fortis at Rs. 8,358 crores. The buyout efforts of Manipal have been backed by US private equity firm TPG.
Midmark India, maker of medical equipment, is planning to set up its 15th center in the near future; the manufacturing unit is said to be set up in Andhra Pradesh or in Telengana.
Suki, a California-based, health-tech startup founded by former Flipkart executive in 2017 is said to have raised a new round of capital of $15 million.
An investigation on 2 different theories about the hereditary ways in which migraines are found in family lines was conducted by a transatlantic team.
The Patient-Centered Outcomes Researcher Institute (PCORI), a study to look at more effective ways to tackle uncontrolled hypertension using mHealth, was funded $6.5 million to the researchers of the University of California and San Francisco. The research includes whether the patients can care for themselves better at home through mHealth devices, compare to the doctors’ office.
Expansion Includes the Joint Development of Moderna’s KRAS Oncogene Program and Other Potential mRNA Cancer Vaccines; Merck to Make Equity Investment in Moderna
The only shingles vaccine to achieve ≥90% efficacy across all age groups studied
Lately, Biotech and immunotherapy have been widely covered by media, but there’s more to healthcare than taking leaps of faith on new tech. New companies are addressing administrative functions, personalized medicine, and proactive wellness in their approach to the health industry.
Several Mobile-Health companies are joining hands to create a clinician-facing platform for assuring data quality and patient identification in remote patient monitoring programs.
Flatiron announced a three-year agreement with Bristol-Myers Squibb (BMS) a leading pharma company from the US. BMS is planning to use Flatiron’s expertise to expand real-world evidence to develop Bristol’s experimental cancer drugs.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.